70 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2026.
Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Blueprint Medicines Corporation's own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.
Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.
Frequent amendments usually mean worksite or role changes; each one must be covered by a new LCA before the change takes effect.
Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.
Median offered wage is 24% above the DOL prevailing wage across 5 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.
No additional recruitment or non-displacement attestations apply.
Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.
Yes — Blueprint Medicines Corporation sponsors H-1B workers, with 70 certified LCAs on file (FY2021–FY2026), including 3 in FY2026. The median certified salary is $140,000 (P25 $128,133, P75 $164,622). With a 31% transfer share, this employer actively accepts H-1B transfers. 100% of its certified filings meet or exceed the prevailing wage.
Blueprint Medicines Corporation H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2026).
Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.
The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.
Levels I–IV are DOL prevailing-wage experience tiers; 63% of filings are senior-level (III–IV).
| Fiscal year | Certified | Denied | Withdrawn | Total |
|---|---|---|---|---|
| FY2021 | 8 | 0 | 0 | 8 |
| FY2022 | 22 | 0 | 0 | 22 |
| FY2023 | 12 | 0 | 0 | 12 |
| FY2024 | 10 | 0 | 0 | 10 |
| FY2025 | 15 | 0 | 0 | 15 |
| FY2026 | 3 | 0 | 0 | 3 |
Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.
| Job title | Salary | Level | Location | Filed | Status |
|---|---|---|---|---|---|
Associate Director, Statistical Programmer I-200-25113-893856 | $213,126/yr | IV | Cambridge, MA | Apr 23, 2025 | Certified |
Principal Biostatistical Programmer I-200-24346-535267 | $192,006/yr | IV | Cambridge, MA | Dec 11, 2024 | Certified |
Associate Director, Research & Clinical Development QA I-200-24299-433446 | $195,524/yr | IV | Cambridge, MA | Oct 25, 2024 | Certified |
Scientist I, Biology I-200-24241-299638 | $134,892/yr | III | Cambridge, MA | Aug 28, 2024 | Certified |
Senior Manager, Packaging Engineer I-200-24158-080707 | $165,000/yr | IV | Pittsford, NY | Jun 06, 2024 | Certified |
Senior Scientist I, Analytical Development I-200-21273-616452 | $145,000/yr | IV | Cambridge, MA | Sep 30, 2021 | Certified |
Senior Manager, Drug Safety & Pharmacovigilance Operations I-200-21235-539058 | $150,000/yr | II | Cambridge, MA | Aug 23, 2021 | Certified |
Scientist II, Biology I-200-21235-539052 | $139,063/yr | III | Cambridge, MA | Aug 23, 2021 | Certified |
Senior Research Associate I-200-21215-499519 | $105,000/yr | III | Cambridge, MA | Aug 03, 2021 | Certified |
Senior Scientist II, Cheminformatics I-200-21168-408239 | $130,000/yr | IV | Cambridge, MA | Jun 17, 2021 | Certified |
Vice President, Therapy Area Lead I-200-21154-366920 | $230,000/yr | IV | Cambridge, MA | Jun 03, 2021 | Certified |
Senior Biostatistician I-200-21154-366918 | $127,000/yr | III | Cambridge, MA | Jun 03, 2021 | Certified |
Scientist I, Computational Biology I-200-21154-366917 | $110,000/yr | II | Cambridge, MA | Jun 03, 2021 | Certified |
Sr. Manager Drug Safety & Pharmacovigilance Operations I-200-21084-174865 | $110,000/yr | I | Cambridge, MA | Mar 25, 2021 | Certified |
One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.
Worker positions by LCA filing purpose, summed across FY2021–FY2026 disclosure records.
Most active filing months: Apr and Jul — useful for timing transfer conversations.
Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.
5 states · 8 cities
The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:
Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.
Get my private gap check →